The optimization of recombinant antibody production in Chinese Hamster Ovary (CHO-K1) cells is a crucial aspect of biopharmaceutical development. To maximize production, various approaches are employed, including protein engineering of the host cells and optimization of media conditions. Moreover, implementation of advanced bioreactors can signif